newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

business / news / / Boston.com

Eli Lilly will acquire Boston-based cancer biotech Kelonia Therapeutics for $7 billion.

Eli Lilly will acquire Kelonia Therapeutics for up to $7 billion, including $3.25 billion upfront.

KEY POINTS
COMPANIES
Read the full story on Boston.com →
Share X LinkedIn

Summarized by Newsio from Boston.com. How we summarize →